Startup Creasphere Batch #3 has come to a successful end. 12 start-ups (6-6 collaborating with Sanofi Consumer Healthcare and Roche Diagnostics) presented the results of their co-creation pilots.
3+1 highlights from the current batch:
The start-up incubator is growing and attracts new partners, such as Lonza and Gates Foundation
The start-up selection process is tough. Out of 400 screened companies, 12 made it to the current batch. Some of them will continue the collaboration with the corporate partners.
Roche Diagnostics experimented with new sensor technologies from Blumio and SteadySense and collaborated with MeshBio, a Singapore-based predictive analytics startup for diagnosis and management of chronic diseases.
Sanofi Consumer Health was also interested in diagnostics solutions. ResApp can diagnose and measure the severity of a wide range of chronic and acute respiratory diseases, while Biomes develops and commercializes NGS-based intestinal flora tests.
New exciting digital health solutions are coming soon. Startup Creasphere Batch 4 opening is taking place on the 11th of March 2020.